ticker=KERX Alder BioPharmaceuticals, Inc. https://rdinvesting.com/news/?ticker=ALDR Keryx Biopharmaceuticals …
Stock Hunter PRESENTS : PINKSHEETS: ECOF) Eco2 Forests Inc., (NASDAQ) MVIS -Microvision, Inc., (OTCBB: IWEB) IceWEB, Inc., (OTCBB: IMGG) Imaging3, Inc., (PINKSHEETS: CCTC) Clean Coal Technologies, Inc., …
A month has gone by since the last earnings report for Keryx Biopharmaceuticals, Inc. KERX. Shares have added about 5% in that time frame, outperforming the market. Will the recent positive trend continue leading up to the stock's next …
Yahoo!8mon
Keryx Biopharmaceuticals (NASDAQ: KERX), American Superconductor Corp (NASDAQ ... are all expected to be lower …
Keryx Biopharmaceuticals, Inc. KERX is expected to report first-quarter 2017 results on May 4. Last quarter, the company missed expectations by 18.52%. In fact, Keryx’s performance over the last four quarters has been disappointing. The …
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on KERX at https://www.zacks.com/ap/KERX Keywords: Keryx …
Keryx Biopharmaceuticals (NASDAQ: KERX) crossed its earlier 52-week high of $1.88 and touched a new 52-week high at $2.63 in today’s morning trade. Currently the stock is trading at $2.26, up 45% on 18.03 million shares – over 6X than …
Mr. Douglas M Jermasek is appointed as Vice President of Marketing and Strategy of the Comapny. Effective July 1, 2016. He has more than 20 years of biopharmaceutical strategic marketing experience. Prior to joining Keryx, from 2002 to …
Keryx Biopharmaceuticals, Inc. KERX is expected to report second-quarter 2016 results on Aug 3. Keryx’s track record has been disappointing so far. Over the four trailing quarters, the company posted an average negative earnings surprise …
Investors in Keryx Biopharmaceuticals, Inc. KERX need to pay close attention to the stock based on moves in the options market lately. That is because the Dec 15, 2017 $10 Call had some of the highest implied volatility of all equity options …